Effects of Global O-GlcNAcylation on Galectin Gene-expression Profiles in Human Cancer Cell Lines
Ali A Sherazi1, Komal A Jariwala1, Amanda N Cybulski1
1Department of Biology, The University of Western Ontario, London, ON, Canada.
Background/Aim:
The effects of O-linked β-N-acetyl-D-glucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA) inhibitors on galectin gene expression profiles were examined in MCF7, HT-29, and HL-60 cancer cell lines.
Materials And Methods:
Cell cultures were treated for 24 h with OGA inhibitor thiamet G or OGT inhibitor 2-acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-5-thio-α-D-glucopyranose, and global O-GlcNAc levels and expression of galectin genes were determined using an immunodot blot assay and real-time quantitative polymerase chain reaction.
Results:
Two galectin genes, LGALS3 in MCF7 cells and LGALS12 in HL-60 cells, were up-regulated by O-GlcNAc, whereas other cell-specific galectins were unresponsive to changes in O-GlcNAc level. Of interest, basal levels of O-GlcNAc in resting HL-60 and HT-29 cells were significantly higher than those in cells differentiated into neutrophilic or enterocytic lineages, respectively.
Conclusion:
O-GlcNAc-mediated signaling pathways may be involved in regulating the expression of only a limited number of galectin genes. Additional O-GlcNAc-dependent mechanisms may work at the protein level (galectin secretion and intracellular localization) and warrant further investigation.
Insights
Inhibitors of O-linked β-N-acetyl-D-glucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA) selectively modulated galectin gene expression. O-GlcNAc signaling impacts a limited set of galectin genes, suggesting protein-level regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- O-linked β-N-acetyl-D-glucosamine (O-GlcNAc) is a dynamic post-translational modification regulating diverse cellular processes.
- Galectins are a family of β-galactoside-binding proteins implicated in cancer progression and immune responses.
Purpose of the Study:
- To investigate the impact of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) inhibition on galectin gene expression profiles in human cancer cell lines.
- To elucidate the role of O-GlcNAc signaling in the regulation of galectin gene expression.
Main Methods:
- MCF7, HT-29, and HL-60 cancer cell lines were treated with OGT or OGA inhibitors.
- Global O-GlcNAc levels were assessed using immunodot blot assays.
- Galectin gene expression was quantified using real-time quantitative polymerase chain reaction (RT-qPCR).
Main Results:
- O-GlcNAc significantly up-regulated LGALS3 in MCF7 cells and LGALS12 in HL-60 cells.
- Other cell-specific galectins showed no significant response to altered O-GlcNAc levels.
- Basal O-GlcNAc levels were higher in resting HL-60 and HT-29 cells compared to differentiated cells.
Conclusions:
- O-GlcNAc-mediated signaling pathways appear to regulate a restricted subset of galectin genes.
- Further research is warranted to explore O-GlcNAc-dependent mechanisms at the protein level, including galectin secretion and localization.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Cell Specific Gene Expression
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability


